Discover open access scientific publications

Search, annotate, share and cite publications

Publications by John J.V. McMurray

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

New England Journal of Medicine
Medicine
2010English

Response to Letter Regarding Article, "Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Heart Failure With Reduced Ejection Fraction: Comparison of Patient Characteristics and Clinical Outcomes Within Asia and Between Asia, Europe and the Americas

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Is Heart Rate a Risk Marker in Patients With Chronic Heart Failure and Concomitant Atrial Fibrillation? Results From the MAGGIC Meta-Analysis

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2015English

Insulin Treatment and Clinical Outcomes in Patients With Diabetes and Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Effect of Digoxin in Patients With Heart Failure and Mid-Range (Borderline) Left Ventricular Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Contribution of Cardiac and Extra-Cardiac Disease Burden to Risk of Cardiovascular Outcomes Varies by Ejection Fraction in Heart Failure

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Redefining Heart Failure Phenotypes Based on Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Rationale and Design of the Phase 2b Clinical Trials to Study the Effects of the Partial Adenosine A1-Receptor Agonist Neladenoson Bialanate in Patients With Chronic Heart Failure With Reduced (PANTHEON) and Preserved (PANACHE) Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy